Fortress Biotech Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	255.84	79.38	57.26	80.93	178.27	305.74
Cash & Short-Term Investments	255.84	79.38	57.26	80.93	178.27	305.74
Cash Growth	180.10%	38.63%	-29.24%	-54.60%	-41.69%	31.02%
Accounts Receivable	24.99	29.78	10.23	15.22	28.21	23.11
Other Receivables	0.52	0.16	0.17	0.17	0.14	0.68
Total Trade Receivables	25.51	29.94	10.4	15.39	28.35	23.79
Inventory	9.29	9.62	14.43	10.21	14.16	9.86
Other Current Assets	4.84	4.9	8.28	10.5	9.66	7.07
Total Current Assets	295.48	123.84	90.37	117.02	230.43	346.46
Net Property, Plant & Equipment	14.25	14.82	17.12	23.5	33.01	34.07
Other Intangible Assets	26.48	27.61	31.86	20.29	27.2	12.55
Long-Term Investments	18.71	17.66	2.59	-	-	-
Other Long-Term Assets	1.96	1.62	2.28	6.72	3.66	3.42
Total Assets	356.87	185.55	144.22	167.53	294.3	396.5
Accounts Payable	92.99	47.13	65.5	73.56	97.45	90.66
Short-Term Debt	2.5	-	-	-	2.95	0.81
Current Portion of Long-Term Debt	-	-	-	3.93	2.05	-
Current Portion of Leases	2.22	2.13	2.62	2.52	2.45	2.1
Unearned Revenue	-	-	-	-	-	2.61
Other Current Liabilities	5.69	0.49	3.28	4.89	22.82	4.86
Total Current Liabilities	103.39	49.74	71.4	84.91	127.72	101.04
Long-Term Debt	36.88	52.42	57.96	60.86	91.73	42.94
Long-Term Leases	12.03	12.67	14.75	18.28	21.57	20.99
Other Long-Term Liabilities	2.2	8.53	1.76	1.89	3.26	5.66
Total Long-Term Liabilities	51.11	73.62	74.47	81.03	116.56	69.58
Total Liabilities	154.5	123.37	145.87	165.94	244.28	170.63
Preferred Stock	0	0	0	0	0	0
Common Stock	0.03	0.03	0.03	0.02	0.01	0.1
Additional Paid-in Capital	785.85	783.89	763.57	717.4	675.94	656.03
Retained Earnings	-623.68	-734.05	-740.87	-694.87	-634.23	-547.46
Total Common Shareholders' Equity	162.21	49.87	22.74	22.54	41.72	108.67
Minority Interest	40.17	12.31	-24.38	-20.96	8.3	117.2
Shareholders' Equity	202.37	62.18	-1.64	1.59	50.03	225.88
Total Liabilities & Equity	356.87	185.55	144.22	167.53	294.3	396.5
Total Debt	53.63	67.22	75.34	85.59	120.75	66.84
Net Cash (Debt)	202.21	12.17	-18.07	-4.67	57.52	238.9
Net Cash Growth	1562.26%	-	-	-	-75.92%	52.23%
Net Cash Per Share	6.69	0.44	-0.87	-0.57	9.71	43.86
Book Value	162.21	49.87	22.74	22.54	41.72	108.67
Book Value Per Share	5.37	1.79	1.09	2.78	7.04	19.95
Tangible Book Value	135.73	22.27	-9.13	2.26	14.52	96.12
Tangible Book Value Per Share	4.49	0.80	-0.44	0.28	2.45	17.65

SEC Filings: 10-K · 10-Q